Abstract
Purpose
Postoperative changes in gut microbiota may occur in patients undergoing Roux-en-Y gastric bypass surgery. In this study, we evaluate the impact of administering probiotic tablets on the gastrointestinal function and metabolic status of these patients.
Materials and Methods
This double-blinded randomized clinical trial was conducted from 2021 to 2022 on 135 Roux-en-Y surgery candidates. The intervention group underwent the surgical procedure and started receiving probiotic supplements (Familact Co.) 1 week after surgery; the control group received a placebo. The laboratory and anthropometric data were measured and analyzed before and 3 and 6 months after the intervention. GIQLI questionnaire was also used at the beginning and 6 months after the intervention to evaluate GI symptoms.
Results
We observed significantly reduced BMI in both groups after surgeries (P < 0.001). The levels of FBS and HbA1C were significantly lower in the probiotic group compared to the placebo in 3 months (P = 0.02 and P = 0.001, respectively) and 6 months (P < 0.001 for both) after the intervention. The levels of vitamin B12 increased significantly in the probiotic group (P < 0.001), and the values were substantially higher than the placebo group in 3 and 6 months (P < 0.001), respectively. Analysis of the GIQLI questionnaire before and 6 months after interventions also revealed significant improvement in the GIQLI score in both groups (P < 0.001 for probiotics and P = 0.03 for placebo).
Conclusion
Probiotic supplement administration following RYGB improves patients’ vitamin and metabolic profile, as well as GI function, although it cannot significantly affect weight loss.
Graphical Abstract
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11695-024-07225-1/MediaObjects/11695_2024_7225_Figa_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-024-07225-1/MediaObjects/11695_2024_7225_Fig1_HTML.png)
Similar content being viewed by others
References
Upadhyay J, Farr O, Perakakis N, et al. Obesity as a disease. Med Clin. 2018;102(1):13–33.
Babak A, Rouzbahani R, Nejad RK, et al. Comparison of nutritional behaviors and physical activities between overweight/obese and normal-weight adults. Adv Biomed Res. 2019;8.
Chooi YC, Ding C, Magkos F. The epidemiology of obesity. Metabolism. 2019;92:6–10.
Bray GA, Frühbeck G, Ryan DH, et al. Management of obesity. Lancet. 2016;387(10031):1947–56.
Arterburn DE, Telem DA, Kushner RF, et al. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324(9):879–87.
Lupoli R, Lembo E, Saldalamacchia G, et al. Bariatric surgery and long-term nutritional issues. World J Diabetes. 2017;8(11):464.
Pucci A, Batterham R. Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different. J Endocrinol Invest. 2019;42(2):117–28.
Wang L, Yao L, Yan P, et al. Robotic versus laparoscopic Roux-en-Y gastric bypass for morbid obesity: a systematic review and meta-analysis. Obes Surg. 2018;28(11):3691–700.
Guan B, Yang J, Chen Y, et al. Nutritional deficiencies in Chinese patients undergoing gastric bypass and sleeve gastrectomy: prevalence and predictors. Obes Surg. 2018;28(9):2727–36.
Lombardo M, Franchi A, Padua E, et al. Potential nutritional deficiencies in obese subjects 5 years after bariatric surgery. Bariatric Surg Pract Patient Care. 2019;14(3):125–30.
Patterson E, Ryan PM, Cryan JF, et al. Gut microbiota, obesity and diabetes. Postgrad Med J. 2016;92(1087):286–300.
Antoniewicz A, Kalinowski P, Kotulecka KJ, et al. Nutritional deficiencies in patients after Roux-en-Y gastric bypass and sleeve gastrectomy during 12-month follow-up. Obes Surg. 2019;29(10):3277–84.
Gérard P. Gut microbiota and obesity. Cell Mol Life Sci. 2016;73(1):147–62.
Keleidari B, Mahmoudie M, Anaraki AG, et al. Six month-follow up of laparoscopic sleeve gastrectomy. Adv Biomed Res. 2016;5.
Zheng Z, Hu Y, Tang J, et al. The implication of gut microbiota in recovery from gastrointestinal surgery. Front Cell Infect Microbiol. 2023;13:1110787.
Lyo V, Plescia T, Chirco AR. The impact of bariatric surgery on the development of small intestinal bacterial overgrowth (SIBO). J Am Coll Surg. 2021;233(5, Supplement 2):e9–10.
Baothman OA, Zamzami MA, Taher I, et al. The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis. 2016;15(1):1–8.
Barathikannan K, Chelliah R, Rubab M, et al. Gut microbiome modulation based on probiotic application for anti-obesity: a review on efficacy and validation. Microorganisms. 2019;7(10):456.
Dahiya DK, Puniya M, Shandilya UK, et al. Gut microbiota modulation and its relationship with obesity using prebiotic fibers and probiotics: a review. Front Microbiol. 2017;8:563.
Eypasch E, Williams JI, Wood-Dauphinee S, et al. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg. 1995;82(2):216–22.
Woodard GA, Encarnacion B, Downey JR, et al. Probiotics improve outcomes after Roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13(7):1198–204.
Fernandes R, Beserra BT, Mocellin MC, et al. Effects of prebiotic and synbiotic supplementation on inflammatory markers and anthropometric indices after Roux-en-Y Gastric bypass: a randomized, triple-blind, placebo-controlled pilot study. J Clin Gastroenterol. 2016;50(3):208–17.
Ramos MRZ, de Oliveira CL, Wagner NRF, et al. Effects of Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 supplementation on nutritional and metabolic parameters in the early postoperative period after Roux-en-Y gastric bypass: a randomized, double-blind, placebo-controlled trial. Obes Surg. 2021;31(5):2105–14.
Cook J, Lehne C, Weiland A, et al. Gut microbiota, probiotics and psychological states and behaviors after bariatric surgery—a systematic review of their interrelation. Nutrients. 2020;12(8):2396.
Ciobârcă D, Cătoi AF, Copăescu C, et al. Bariatric surgery in obesity: effects on gut microbiota and micronutrient status. Nutrients. 2020;12(1):235.
Gutiérrez-Repiso C, Moreno-Indias I, Tinahones FJ. Shifts in gut microbiota and their metabolites induced by bariatric surgery. Impact of factors sha** gut microbiota on bariatric surgery outcomes. Rev Endocr Metab Disord. 2021;1–20.
Abenavoli L, Scarpellini E, Colica C, et al. Gut microbiota and obesity: a role for probiotics. Nutrients. 2019;11(11):2690.
Chen J-C, Lee W-J, Tsou J-J, et al. Effect of probiotics on postoperative quality of gastric bypass surgeries: a prospective randomized trial. Surg Obes Relat Dis. 2016;12(1):57–61.
Swierz MJ, Storman D, Staskiewicz W, et al. Efficacy of probiotics in patients with morbid obesity undergoing bariatric surgery: a systematic review and meta-analysis. Surg Obes Relat Dis. 2020;16(12):2105–16.
Wagner NRF, Ramos MRZ, de Oliveira CL, et al. Effects of probiotics supplementation on gastrointestinal symptoms and SIBO after Roux-en-Y gastric bypass: a prospective, randomized, double-blind, placebo-controlled trial. Obes Surg. 2021;31(1):143–50.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards (Ethics code: IR.MUI.MED.REC.1399.849, Iranian Registry of Clinical Trials (IRCT) code: IRCT20220702055340N1).
Consent to Participate
Informed consent was obtained from all individual participants included in the study.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key points
• Bariatric surgery is effective in lowering the BMI and improving the metabolic profile and subjective GI symptoms in patients with obesity.
• Probiotics could result in a more significant post-op reduction in FBS and HbA1C.
• An increase in vitamin B12 level and GIQLI scores compared to placebo was observed in patients who received probiotics.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Melali, H., Abdolahi, A., Sheikhbahaei, E. et al. Impact of Probiotics on Gastrointestinal Function and Metabolic Status After Roux-en-Y Gastric Bypass: A Double-Blind, Randomized Trial. OBES SURG 34, 2033–2041 (2024). https://doi.org/10.1007/s11695-024-07225-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-024-07225-1